Mitral stenosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Mitral stenosis}}
{{Mitral stenosis}}
{{CMG}}; '''Associate Editor-In-Chief:''' [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S.; [[User:Mohammed Sbeih|Mohammed A. Sbeih, M.D.]][mailto:msbeih@perfuse.org]
{{CMG}}; '''Associate Editor-In-Chief:''' [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S.; [[User:Mohammed Sbeih|Mohammed A. Sbeih, M.D.]][mailto:msbeih@wikidoc.org]


==Overview==
==Overview==

Revision as of 15:54, 2 November 2012

Mitral Stenosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Mitral Stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Stages

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

Echocardiography

Cardiac MRI

Cardiac Catheterization

Treatment

Overview

Medical Therapy

Percutaneous Mitral Balloon Commissurotomy (PMBC)

Surgery

Follow Up

Prevention

Case Studies

Case #1

Mitral stenosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mitral stenosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMitral stenosis epidemiology and demographics

CDC on Mitral stenosis epidemiology and demographics

Mitral stenosis epidemiology and demographics in the news

Blogs on Mitral stenosis epidemiology and demographics

Directions to Hospitals Treating Mitral Stenosis

Risk calculators and risk factors for Mitral stenosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.; Mohammed A. Sbeih, M.D.[2]

Overview

In developed countries, the prevalence of mitral stenosis continues to decline as the prevalence of rheumatic fever declines. Currently, the estimated incidence in the United States is 1:100,000. The incidence in higher in developing countries.

Prevalence

Developed countries

  • Despite a decline in rheumatic fever, rheumatic disease remains the major cause of mitral valve stenosis. The prevalence of rheumatic disease in developed nations is steadily declining. In United States the prevalence rate is less than 5 per 100,000 persons [1]. This could be attributed to the introduction of penicillin or a change in the virulence of the Streptococcus.
  • In countries with low prevalence of rheumatic disease, mitral stenosis may be congenital [2]. Though the incidence is low, these patients have high mortality rates.

Developing countries

Developing countries have higher rates of rheumatic fever and consequently higher rates of mitral stenosis with prevalence of more than 10 cases per 1,000 in India and 4-10 cases per 1,000 in China, Russia, Africa and Australia [1].

Gender

Though rheumatic fever occurs in equal numbers in males and females, two thirds of all patients with rheumatic mitral stenosis are females [3].

Age

Rheumatic fever is a disease of childhood. Mitral stenosis usually becomes symptomatic in the third or fourth decade of life.

References

  1. 1.0 1.1 Seckeler MD, Hoke TR (2011). "The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease". Clin Epidemiol. 3: 67–84. doi:10.2147/CLEP.S12977. PMC 3046187. PMID 21386976.
  2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172.
  3. Movahed MR, Ahmadi-Kashani M, Kasravi B, Saito Y (2006). "Increased prevalence of mitral stenosis in women". J Am Soc Echocardiogr. 19 (7): 911–3. doi:10.1016/j.echo.2006.01.017. PMID 16825001.

Template:WH Template:WS